Pharmacokinetics of oseltamivir in infants under the age of 1 year

BACKGROUND: Oseltamivir is the only antiviral treatment recommended for influenza in young children over the age of 1 year. There is scant data on oseltamivir pharmacokinetics (PK) in infants <1 year. We set out to perform PK measurements in infants who received oseltamivir. METHODS: This study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixit, Rashmi, Matthews, Slade, Khandaker, Gulam, Walker, Karen, Festa, Marino, Booy, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011461/
https://www.ncbi.nlm.nih.gov/pubmed/27596232
http://dx.doi.org/10.1186/s40169-016-0118-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011461/
https://www.ncbi.nlm.nih.gov/pubmed/27596232
http://dx.doi.org/10.1186/s40169-016-0118-1

Ejemplares similares